Coronary Track

Choice of Antiplatelet Therapy for ACS

Friday, April 20
10:30 AM - 10:40 AM
Location: Lullwater Ballroom

David J. Moliterno, MD

Chairman, Department of Internal Medicine
University of Kentucky
University of Kentucky

Dr. David J. Moliterno is Chairman of Internal Medicine at the University of Kentucky. He has been involved with interventional cardiology for 25 years. Dr. Moliterno has helped lead numerous large-scale clinical trials involving over $1 billion dollars in clinical research. He was the Editor-in-Chief for CathSAP-3 and CathSAP-4 as is the current Editor-in-Chief of JACC: Cardiovascular Interventions. He is the author or coauthor of over 350 publications, including 60 book chapters, and editor of 7 textbooks. He has been the primary author of publications in Annals of Internal Medicine, Circulation, JACC, JAMA, Lancet, BMJ, and the New England Journal of Medicine.


Send Email for David Moliterno


Choice of Antiplatelet Therapy for ACS

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Choice of Antiplatelet Therapy for ACS